Rifaximin Tablet 400mg

Description

Rifaximin Tablet 400mg is an oral antibiotic primarily used to treat certain gastrointestinal infections, including traveler’s diarrhea and irritable bowel syndrome with diarrhea (IBS-D). It works by inhibiting the growth of bacteria in the intestines, providing relief from symptoms, and preventing complications.

Key Features

• Broad-Spectrum Antibiotic: Effectively targets a wide range of gastrointestinal bacteria.
• Non-Systemic Action: Limited absorption into the bloodstream, focusing its action in the intestines.
• Convenient Dosage Form: Easy-to-swallow tablets.
• Relieves Symptoms: Provides relief from diarrhea, abdominal pain, and bloating.
• Well-Tolerated: Generally well-tolerated with minimal side effects.

Ingredients

• Active Ingredient: Rifaximin 400mg
• Inactive Ingredients: Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide.

Directions for Use

Take Rifaximin 400mg tablets orally, with or without food, as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Dosage Information

The recommended dosage varies based on the condition being treated. For traveler’s diarrhea, the typical dosage is one tablet taken three times a day for three days. For IBS-D, consult your healthcare provider for the appropriate dosage and duration.

Precautions

• Allergy Alert: Do not use if allergic to rifaximin or similar medications.
• Medical Conditions: Inform your doctor if you have liver disease or any other serious medical conditions.
• Pregnancy & Breastfeeding: Consult a healthcare professional before use if you are pregnant or breastfeeding.

Side Effects

Common side effects may include nausea, dizziness, and headache. Rarely, more severe side effects like allergic reactions or changes in liver function may occur. Contact your healthcare provider if you experience any unusual symptoms.

Storage Instructions

Store at room temperature, away from moisture and heat. Keep out of reach of children and pets. Do not use if the packaging is damaged or tampered with.

Manufacturer Information

Manufactured by [Manufacturer Name], a trusted leader in pharmaceutical products, known for high-quality standards and rigorous testing procedures.

Benefits

• Effective Relief: Alleviates symptoms of gastrointestinal infections.
• Targeted Action: Acts locally in the gut with minimal systemic absorption.
• Reduces Recurrence: Helps prevent the recurrence of symptoms in IBS-D patients.

FAQs

• Q: Can I take Rifaximin with other medications?
  • A: Consult your healthcare provider, as Rifaximin may interact with other drugs.
• Q: How long does it take to see results?
  • A: Results may vary; some may notice improvement within a few days.
• Q: Is Rifaximin safe for long-term use?
  • A: Long-term use should be under the supervision of a healthcare provider.

…………………………………………

Legal Disclaimer
Unless expressly indicated in the product description, Doseway is not the manufacturer of the product on our website. While we strive to ensure that the product information on our website is accurate, manufacturers may alter their product details. Actual product packaging and materials may contain additional or different information than what is displayed on our website. For any specific product queries, please get in touch with the manufacturer directly.

For medicinal products, the content on our website is not intended to diagnose, treat, cure, or prevent any disease or health condition, nor is it a substitute for advice from medical practitioners, pharmacists, or other licensed healthcare professionals. If you suspect you have a medical problem, contact your healthcare provider immediately. Always read the labels, warnings, and instructions provided with the product before using or consuming it, and do not solely rely on the information presented on our website.

For further inquiries or assistance, please contact us at support@doseway.com or call our helpline at +92 318 6144 650.

…………………………………………